Davis Polk advised the representatives of the several underwriters in the offering.Akoya Biosciences, Inc. executed its $151.3 million initial public offering of 7,567,000 shares of common stock. Akoya…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Martina Bellini
…
This content is for Standard 1 Year members only. LoginJoin Now